Sophiris Bio, Inc. (SPHS) Social Stream
Sophiris Bio Inc (SPHS) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering Sophiris Bio Inc.
|Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
Price Target Last Issued March 11, 2020
SPHS Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- SPHS has a higher number of analysts covering the stock than nearly none of all US stocks.
- The variance in analysts' estimates of SPHS is less than almost 100% of all US stocks.
- SPHS has a higher upside potential (average analyst target price relative to current price) than 99.86% of Pharmaceutical Products stocks.
- The average analyst price target of SPHS is greater than 4.48% of Pharmaceutical Products stocks.
Is SPHS a Buy, Hold or Sell? See the POWR Ratings now!